Trial Profile

PROMPT (PONV Rescue Outcomes After Amisulpride Treatment)

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 10 Apr 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amisulpride (Primary)
Indications Postoperative nausea and vomiting
Focus Therapeutic Use
Acronyms PROMPT
Sponsors Acacia Pharma

Most Recent Events

05 Apr 2023 Status changed from not yet recruiting to withdrawn prior to enrolment. (sponsor terminated the study)
06 Oct 2022 Planned initiation date changed from 1 Apr 2022 to 1 Nov 2022.
14 Feb 2022 Planned initiation date changed from 1 Jul 2021 to 1 Apr 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com